How many courses of pomalidomide do you need to take before stopping? What are the treatment arrangements and treatment cycles?

Pomalidomide is an immunomodulator that is mainly used to treat relapsed or refractory multiple myeloma and is often used in combination with dexamethasone. There is no unified "fixed course" standard for how many courses of treatment are required before discontinuing the drug, because the treatment cycle and discontinuation time of the drug are mainly determined based on the patient's specific condition, treatment response and adverse reactions, and have certain individualized characteristics.

Generally speaking, pomalidomide takes "28 days as a treatment cycle." The drug is taken on the first 21 days of a cycle, and the drug is stopped for the next 7 days. Treatment is often started with a lower dose (such as 4mg/day), and efficacy and tolerability are gradually observed. Treatment can be continued for multiple cycles as long as the patient is responding to the drug, the disease remains under control, and side effects are manageable. In clinical practice, some patients may need to continue taking medication for 6 months or even longer, while other patients may discontinue medication after 3-4 cycles due to disease progression or obvious side effects.

Treatment schedules are usually regularly evaluated by a hematologist or oncologist based on the patient's response to and tolerance of treatment. During the treatment, doctors will use blood tests, imaging evaluations and other methods to judge the efficacy, such as whether the tumor load is reduced, whether the M protein is reduced, etc. Once a patient achieves partial remission or complete remission, doctors may continue treatment or switch to maintenance treatment; however, if the efficacy is poor or the side effects are intolerable, treatment may be adjusted in advance or terminated.

It is important to note that patients should not decide the length of treatment or stop medication suddenly. Even if symptoms are relieved, your doctor still needs to evaluate whether it is safe to stop the medication or move to the next stage of treatment. At the same time, regular reexaminations should be conducted after discontinuation of medication to monitor for signs of recurrence. Although pomalidomide cannot be used indefinitely, its efficacy is based on long-term regular use. Scientific arrangement of treatment cycles and courses is the key to improving the success rate of treatment.

Reference materials:https://en.wikipedia.org/wiki/Pomalidomide